Erstellt am 2021/02/19, Last modification: 2023/07/19

Autor(en) Titel Quelle Links
Nachman J Allotransplantation in pediatric HL. Blood 2009 Sep 3; 114: 2008    
Nägele V, Kratzer A, Zugmaier G, Holland C, Hijazi Y, Topp MS, Gökbuget N, Baeuerle PA, Kufer P, Wolf A, Klinger M Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL. Experimental hematology & oncology 2017, 6: 14    
Nägele V, Zugmaier G, Goebeler ME, Viardot A, Bargou R, Kufer P, Klinger M Relationship of T- and B-cell kinetics to clinical response in patients with relapsed/refractory non-Hodgkin lymphoma treated with blinatumomab. Experimental hematology 2021,S0301-472X00245    
Naik RP, Streiff MB, Haywood C Jr, Nelson JA, Lanzkron S Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. The American journal of medicine 2013, 126: 443    
Namouni F, Doz F, Tanguy ML, Quintana E, Michon J, Pacquement H, Bouffet E, Gentet JC, Plantaz D, Lutz P, Vannier JP, Validire P, Neuenschwander S, Desjardins L, Zucker JM High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. European journal of cancer (Oxford, England : 1990) 1997, 33: 2368    
Naouri M, Schill T, Maruani A, Bross F, Lorette G, Rossler J Successful treatment of ulcerated haemangioma with propranolol. Journal of the European Academy of Dermatology and Venereology : JEADV 2010, 24: 1109    
Netzwerk ActiveOncoKids S2k-Leitlinie: Bewegungsförderung und Bewegungstherapie in der pädiatrischen Onkologie - S2k-Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie - Arbeitsgemeinschaft Netzwerk ActiveOncoKids. AWMF online 10/2021    
The National Academies - National Research Council Report in Brief. Beir VII: Health Risks from Exposure to Low Levels of Ionizing Radiation. National Academy Press 2006    
Narla A, Vlachos A, Nathan DG Diamond Blackfan anemia treatment: past, present, and future. Seminars in hematology 2011, 48: 117    
National Toxicology Program NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea. NTP CERHR MON 2008,:vii-viii, v, ix-III1    
Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 1990, 72: 408    
Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, Sutton L, Zhao H, Garvin JH Jr, Phillips PC Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997, 80: 341    
Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute 2006 Nov 1; 98: 1528    
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E Gene Therapy of the ß-Hemoglobinopathies by Lentiviral Transfer of the ß(A(T87Q))-Globin Gene. Human gene therapy 2016, 27: 148    
Nemes K, Bens S, Bourdeaut F, Hasselblatt M, Kool M, Johann P, Kordes U, Schneppenheim R, Siebert R, Frühwald MC, In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) Rhabdoid Tumor Predisposition Syndrome. GeneReviews 2017    
Nemes K, Frühwald MC Emerging therapeutic targets for the treatment of malignant rhabdoid tumors. Expert opinion on therapeutic targets 2018, 22: 365    
Nemes K, Clément N, Kachanov D, Bens S, Hasselblatt M, Timmermann B, Schneppenheim R, Gerss J, Siebert R, Furtwängler R, Bourdeaut F, Frühwald MC, EU-RHAB consortium The extraordinary challenge of treating patients with congenital rhabdoid tumors-a collaborative European effort. Pediatric blood & cancer 2018, 65:e26999    
Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Woessmann W, Beck O, Flotho C, Grigull L, Driever PH, Schlegel PG, Khurana C, Hering K, Kolb R, Leipold A, Abbink F, Gil-Da-Costa MJ, Benesch M, Kerl K, Lowis S, Marques CH, Graf N, Nysom K, Vokuhl C, Melchior P, Kröncke T, Schneppenheim R, Kordes U, Gerss J, Siebert R, Furtwängler R, Frühwald MC Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK). European journal of cancer 2021, 142: 112    
Nenning UC, Eckert C, Wellmann S, Barth A, Henze G, Seeger K Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia. Journal of the National Cancer Institute 2005, 97: 1091-2; author reply 1093    
Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study. J Clin Oncol 2013, 31: 4496    
Neth O, Seidemann K, Jansen P, Mann G, Tiemann M, Ludwig W, Riehm H, Reiter A Precursor B-cell lymphoblastic lymphoma in childhood and adolescence. Med Pediatr Oncol 2000, 35: 20    
Nettersheim D, Oing C, Schönberger S, Skowron M, Vermeulen M, Müller M, Watolla M, Bremmer F, Pfister D, Calaminus G, Looijenga L, Lorch A, Albers P [Current research on pediatric and adult germ cell tumors : A report from the first "Düsseldorfer Testis Cancer Day"]. Der Urologe 2019, 58: 804    
Neuendank A, Hartmann R, Fengler R, Erttmann R, Zintl F, Koscielniak E, Henze G Interim results of a phase II study with idarubicin in relapsed childhood acute lymphoblastic leukemia. Haematol Blood Transfus 1995, 254    
von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98. Journal of clinical oncology 2010, 28: 2682    
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190    
Neunert CE Individualized treatment for immune thrombocytopenia: predicting bleeding risk. Seminars in hematology 2013, 50 Suppl 1:S55    
Neumann JE, Spohn M, Obrecht D, Mynarek M, Thomas C, Hasselblatt M, Dorostkar MM, Wefers AK, Frank S, Monoranu CM, Koch A, Witt H, Kool M, Pajtler KW, Rutkowski S, Glatzel M, Schüller U Molecular characterization of histopathological ependymoma variants. Acta neuropathologica 2020, 139: 305    
Newton HB, Henson J, Walker RW Extraneural metastases in ependymoma. J Neurooncol 1992, 14: 135    
Nicholson JC, Punt J, Hale J, Saran F, Calaminus G, Germ Cell Tumour Working Groups of the United Kingdom Children's Cancer Study Group (UKCCSG) and International Society of Paediatric Oncology (SIOP) Neurosurgical management of paediatric germ cell tumours of the central nervous system--a multi-disciplinary team approach for the new millennium. British journal of neurosurgery 2002, 16: 93    
Nickel RS, Hendrickson JE, Haight AE The ethics of a proposed study of hematopoietic stem cell transplant for children with . Blood 2014, 124: 861    
Nickel RS, Hendrickson JE, Haight AE The ethics of a proposed study of hematopoietic stem cell transplant for children with . Blood 2014, 124: 861    
Niemeyer C, Stollmann-Gibbels B, Ebell W, Gaedicke G, Creutzig U Myelodysplastic diseases in childhood. Klin Pädiatr 1992, 204: 190    
Niemeyer C, Stollmann-Gibbels B, Ebell W, Gaedicke G, Creutzig U Myelodysplastic diseases in childhood. Klin Pädiatr 1992, 204: 190    
Niethammer D, Dopfer R, Henze G, Bender-Götze C, Burdach S, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission as part of the treatment strategies within the German BFM-and CoALL-protocols. Haematol Blood Transfus 1992, 34    
Niemeyer C, Arico M, Basso G, Biondi A, Cantu Rajnoldi, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, Veer-Korthof E, van Wering E, Zimmermann M Chronic myelomonocytic leukemia in childhood. Blood 1997, 89: 3534    
Niemeyer C, Fenu S, Hasle H, Mann G, Stary J, van Wering E Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998, 91: 365    
Niehues T, Kapaun P, Harms D, Burdach S, Kramm C, Körholz D, Janka-Schaub G, Göbel U A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia 1999, 13: 614    
Niemeyer C Myelodysplastic syndrome and aplastic anemia in children. Europ School of Oncology 2000, 31    
Niehuis T, Schellong G, Dörffel W, Bucsky P, Gadner H, Körholz D, Göbel U Immunodeficiency and Hodgkin's disease. Klin Pädiatr 2003,im Druck    
Niemeyer C, Kratz C Juvenile myelomonocytic leukemia. Curr Treat Options Oncol 2003, 4: 203    
Niehues T, Weiß M Klassifikation angeborener Immundefekte. Allergologie 2003, 11: 497–503    
Niemeyer C, Kontny U Tumoren der Ewing-Sarkom-Familie, in: Gutjahr P (Hrsg.): Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 491    
Nielsen P, Gaedicke, G Physiologie und Pathophysiologie des Eisenstoffwechsels. In: Helmut Gadner, Gerhard Gaedicke, Charlotte Niemeyer (Hrsg.): Pädiatrische Hämatologie und Onkologie 2006    
Niemeyer C, Meepol J, Hrsg: Gadner H, Gaedicke G, Niemeyer C, Ritter, J Aplastische Anämien. Pädiatrische Hämatologie und Onkologie, Springer Verlag 2006    
Niemeyer C, Ammann R Zweitneoplasien, in: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg): Pädiatrische Hämatologie und Onkologie. Springer Medizin Verlag Heidelberg 2006 2006, 1094    
Niewerth D, Creutzig U, Bierings MB, Kaspers GJ A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia. Blood 2010,    
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, Klein C, Schlegel PG, Heinzmann A, Schneider M, Starý J, van den Heuvel-Eibrink MM, Hasle H, Locatelli F, Sakai D, Archambeault S, Chen L, Russell RC, Sybingco SS, Ohh M, Braun BS, Flotho C, Loh ML Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 2010, 42: 794    
Niemeyer CM, Baumann I Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2011, 2011, 84    
Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Catala A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C, Yoshimi A Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica 2015, 100: 17    
Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen(I) Grundlagenpapier. Bundesgesundheitsblatt 2017, 60: 674    
Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen(I) Grundlagenpapier. Bundesgesundheitsblatt 2017, 60: 674    
Niemeyer C, Eggert A (Hrsg) Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland 2. vollständig überarbeitete Auflage 2018    
Niemeyer C, Kratz C Myelodysplastische Syndrome. in Niemeyer C, Eggert A (Hrsg): Pädiatrische Onkologie und Hämatologie 2018, Springer Verlag; 715    
Niemeyer CM, Flotho C, Lipka DB, Starý J, Rössig C, Baruchel A, Klingebiel T, Micalizzi C, Michel G, Nysom K, Rives S, Schmugge Liner M, Zecca M, Schönung M, Baumann I, Nöllke P, Benettaib B, Biserna N, Poon J, Simcock M, Patturajan M, Menezes D, Gaudy A, van den Heuvel-Eibrink MM, Locatelli F Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial. Blood advances 2021 Jul 27; 5: 2901    
Niktoreh N, Lerius B, Zimmermann M, Gruhn B, Escherich G, Bourquin JP, Dworzak M, Sramkova L, Rossig C, Creutzig U, Reinhardt D, Rasche M Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group. Haematologica 2019, 104: 120    
Nitz A, Kontopantelis E, Bielack S, Koscielniak E, Klingebiel T, Langer T, Paulides M Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncology letters 2013, 5: 311    
Noeker M [Survivors of pediatric cancer. Developmental paths and outcomes between trauma and resilience]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2012, 55: 481    
Nogami K, Shima M New therapies using nonfactor products for patients with hemophilia and inhibitors. Blood 2019 Jan 31; 133: 399    
National Organization for Rare Disorders Neonatal Hemochromatosis. aufgerufen am 14.12.2020    
Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM Medulloblastoma. Nature reviews. Disease primers 2019, 5: 11    
Nowak-Göttl U, Schaudin E, Hoffmann C, Eckhoff-Donovan S, Mertes N, Winkelmann W, Jürgens H Intraoperative clotting factor dilution and activated hemostasis in children with Ewing's sarcoma or osteosarcoma. haematologica 1995, 80: 311    
Nowak-Göttl U, Münchow N, Klippel U, Paulussen M, Bielack S, Ullrich K, Ehrenforth S The course of fibrinolytic proteins in children with malignant bone tumours. Eur J Pediatr 1999, 158 Suppl 3:S151-S153    
Nowak-Goettl U, Heller C, Knoefler R et al. S1-Leitlinie Thrombosen im Kindesalter. Leitlinien Kinderheilkunde und Jugendmedizin 2004, K3    
Nowacki S, Skowron M, Oberthuer A, Fagin A, Voth H, Brors B, Westermann F, Eggert A, Hero B, Berthold F, Fischer M Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma. Oncogene 2008, 27: 3329    
Nowak-Goettl U, Janssen V, Manner D, Kenet G Venous thromboembolism in neonates and children--update 2013. Thrombosis research 2013, 131 Suppl 1:S39    
Nowak J, Seidel C, Pietsch T, Friedrich C, von Hoff K, Rutkowski S, Warmuth-Metz M Ependymoblastoma of the brainstem: MRI findings and differential diagnosis. Pediatric blood & cancer 2014, 61: 1132    
Nowak J, Alkonyi B, Rutkowski S, Homola GA, Warmuth-Metz M Hypertrophic olivary degeneration with gadolinium enhancement after posterior fossa surgery in a child with medulloblastoma. ChNS 2014, 30: 959    
Nowak J, Nemes K, Hohm A, Vandergrift LA, Hasselblatt M, Johann PD, Kool M, Frühwald MC, Warmuth-Metz M Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor. Neuro-oncology 2018 Nov 12; 20: 1672    
Nowak J, Jünger ST, Huflage H, Seidel C, Hohm A, Vandergrift LA, von Hoff K, Rutkowski S, Pietsch T, Warmuth-Metz M MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma. Clinical neuroradiology 2019, 29: 595    
Nurden AT, Freson K, Seligsohn U Inherited platelet disorders. Haemophilia 2012, 18 Suppl 4: 154    
Nustede R, Klimiankou M, Klimenkova O, Kuznetsova I, Zeidler C, Welte K, Skokowa J ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. British journal of haematology 2016, 172: 219    
71 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.